Pereira F., Serrano A., Manzanedo I., Pérez-Viejo E., González-Moreno S., González-Bayón L., Arjona-Sánchez A., Torres J., Ramos I., Barrios M.E., Cascales P., Morales R., Boldó E., García-Fadrique A., Arteaga X., Gutierrez-Calvo A., Sánchez-García S., Asensio E., Ramírez C.P., Artiles M., Vaqué J., Parra P.A., Villarejo P., Muñoz-Casares C., Turienzo E., Calero A., Torrejimeno I.J., Prieto I., Galindo J., Borrego V., Marcello M.E., Rihuete C., Carrasco J., Gomez-Quiles L. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases. BMC Cancer. December 2022. 22. 10.1186/s12885-022-09572-7
AÑO: 2022; IF: 3.8